Abstract
Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Current Pharmaceutical Design
Title: Cytokine Therapeutics for Infectious Diseases
Volume: 6 Issue: 6
Author(s): F. H. Rodriguez, S. Nelson and J. K. Kolls
Affiliation:
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Abstract: Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Export Options
About this article
Cite this article as:
Rodriguez H. F., Nelson S. and Kolls K. J., Cytokine Therapeutics for Infectious Diseases, Current Pharmaceutical Design 2000; 6 (6) . https://dx.doi.org/10.2174/1381612003400641
DOI https://dx.doi.org/10.2174/1381612003400641 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in Analyses of Profens in Biological and Environmental Samples by Liquid Chromatography
Current Pharmaceutical Analysis Genetic Markers of Osteoarthritis
Current Rheumatology Reviews Pregnancy, Programming and Preeclampsia: Gap Junctions at the Nexus of Pregnancy-induced Adaptation of Endothelial Function and Endothelial Adaptive Failure in PE
Current Vascular Pharmacology Medicated Chewing Gum: Patient Compliance Oral Drug Delivery System
Drug Delivery Letters Structural Heterogeneity and Multifunctionality of Lactoferrin
Current Protein & Peptide Science Natural Plants with Antiepileptic Activity-The Present and Future Perspectives
The Natural Products Journal Molecular Imaging of Vascular Inflammation
Current Pharmaceutical Design Evidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
Current Drug Abuse Reviews Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease
Current Medicinal Chemistry Production of Orally Applicable New Drug or Drug Combinations from Natural Origin Capsaicinoids for Human Medical Therapy
Current Pharmaceutical Design Protective Growth Factors for Graft-Versus-Host Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Microglial Activation as a Compelling Target for Treating Acute Traumatic Brain Injury
Current Medicinal Chemistry Immune Response Towards Snake Venoms
Inflammation & Allergy - Drug Targets (Discontinued) Haploidentical Stem Cell Transplantation in Childhood
Current Cancer Therapy Reviews Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) The Influence of Ionizing Radiation on Exosome Composition, Secretion and Intercellular Communication
Protein & Peptide Letters Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Current Pharmaceutical Design Effect of Some Biologically Interesting Substituted Tetrahydro-1,4- Oxazines on Drug Metabolising Enzymes and on Inflammation
Current Drug Metabolism Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus
Current Vascular Pharmacology Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis
Current Respiratory Medicine Reviews